We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Magnetic Resonance (MR) Spectroscopy of Breast Cancer Tissue

This study is currently recruiting participants.
Verified August 2017 by Norwegian University of Science and Technology
Sponsor:
ClinicalTrials.gov Identifier:
NCT00184210
First Posted: September 16, 2005
Last Update Posted: August 22, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborators:
The Research Council of Norway
The Norwegian Women´s Public Health Association
Information provided by (Responsible Party):
Norwegian University of Science and Technology
  Purpose

Breast cancer tissue is collected from women undergoing scheduled surgery for breast cancer. The tissue specimen are analyzed by MR spectroscopy. After MR, the intact tissue specimen can be analyzed by other methods, such as histopathology.

The MR spectral profiles are compared to clinical findings such as the patients diagnosis, lymph node status and tumor size.


Condition
Breast Neoplasms

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: HR MAS MR Spectroscopy of Breast Cancer Tissue

Resource links provided by NLM:


Further study details as provided by Norwegian University of Science and Technology:

Primary Outcome Measures:
  • MRimage of breast cancer tissue [ Time Frame: 0 hour ]

Biospecimen Retention:   Samples With DNA
tissue

Estimated Enrollment: 1000
Actual Study Start Date: January 2000
Estimated Study Completion Date: December 2020
Estimated Primary Completion Date: December 2020 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
women in surgery for breast cancer
Criteria

Inclusion Criteria:

  • Palpable breast cancer lesion
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00184210


Contacts
Contact: Beathe Sitter, PhD +47 73 55 13 53 beathesi@ntnu.no
Contact: Tone F Bathen, PhD +47 73 86 38 44 tone.bathen@ntnu.no

Locations
Norway
Norwegian University of Technology and Science Recruiting
Trondheim, Norway, 7491
Contact: Beathe Sitter, PhD    +47 73 55 13 53    beathesi@ntnu.no   
Sponsors and Collaborators
Norwegian University of Science and Technology
The Research Council of Norway
The Norwegian Women´s Public Health Association
Investigators
Study Chair: Tone F Bathen, PhD Norwegian University of Technology and Science
  More Information

Publications:
Responsible Party: Norwegian University of Science and Technology
ClinicalTrials.gov Identifier: NCT00184210     History of Changes
Other Study ID Numbers: 154080/I30
First Submitted: September 12, 2005
First Posted: September 16, 2005
Last Update Posted: August 22, 2017
Last Verified: August 2017

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Norwegian University of Science and Technology:
Magnetic Resonance Spectroscopy

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases